Related Experiment Video

Updated: Oct 10, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

718

The Correlation Between Bronchopulmonary Dysplasia and Platelet Metabolism in Preterm Infants

Longli Yan1, Zhuxiao Ren1, Jianlan Wang1

  • 1Department of Neonatology, Guangdong Women and Children Hospital, Guangzhou Medical University, Guangzhou, China.

Frontiers in Pediatrics
|December 13, 2021
PubMed

Insights

Platelet metabolism is linked to bronchopulmonary dysplasia (BPD) in premature infants. Infants with BPD showed lower platelet counts but higher platelet activation and thrombopoietin (TPO) levels, suggesting a role in disease development.

Area of Science:

  • Neonatology
  • Hematology
  • Pulmonology

Background:

  • Platelets are crucial for pulmonary vascular development.
  • Thrombocytopenia is prevalent in pulmonary diseases.
  • Limited research exists on platelet involvement in bronchopulmonary dysplasia (BPD).

Purpose of the Study:

  • To investigate the association between platelet metabolism and BPD in preterm infants.
  • To explore platelet counts, megakaryocyte counts, activation markers, and thrombopoietin (TPO) levels in relation to BPD.

Main Methods:

  • A prospective case-control study included preterm infants (<32 weeks gestation, <1,500 g birth weight).
  • Infants were grouped into BPD and control cohorts.
  • Platelet count, circulating megakaryocyte (MK) count, CD62P, CD63, and TPO were measured at 28 days post-birth.

Main Results:

  • Infants with BPD exhibited significantly lower platelet counts (180.3 vs. 345.6 × 10^9/L) compared to controls.
  • Higher circulating MK counts (30.7 vs. 13.3/ml) and elevated CD62P, CD63, and TPO levels were observed in the BPD group.
  • TPO concentration negatively correlated with platelet count in BPD infants with thrombocytopenia.

Conclusions:

  • Platelet metabolism appears to play a role in the pathogenesis of BPD in preterm infants.
  • Mechanisms may involve increased platelet activation and feedback-driven TPO production.

Keywords:
CD62PCD63TPObronchopulmonary dysplasiamegakaryocyteplatelet

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

746

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20